Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christos Tsironis
Observed name:
Τσιρώνης, Χρήστος
Institution:
University Hospital of Ioannina
Observed institution:
University Hospital of Ioannina
ORCID:
0009-0004-9640-8728
Observed ORCID:
0009-0004-9640-8728
OpenAlex ID:
A5123674424
Eptinezumab to prevent difficult-to-treat migraine: prospective, six-month, real-world multicenter evidence from the GRASP study group
2026
·
Emmanouil V. Dermitzakis
, Andreas A. Argyriou
, et al.
·
The Journal of Headache and Pain
·
4
Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group
2026
·
Michail Vikelis
, Dimitrios Rikos
, et al.
·
Neurology International
·
1
PDF
Efficacy of single-dose galcanezumab 240 mg on episodic or refractory chronic cluster headache: prospective, 4-week, real-world evidence from the GRASP study group
2026
·
Michail Vikelis
, Andreas A. Argyriou
, et al.
·
Frontiers in Neurology
·
1
PDF
Effectiveness and safety of sumatriptan 85 mg/naproxen sodium 500 mg combination for acute migraine: prospective real-world evidence from the GRASP Study Group
2026
·
Dimitrios Rikos
, Andreas A. Argyriou
, et al.
·
Frontiers in Neurology
PDF
Consensus Article: Updated Opinion of the Headache Scientific Panel of the Hellenic Neurological Society on the Use of Monoclonal Antibodies and Small Molecules Targeting the Cgrp Pathway in the Preventive Treatment of Episodic or Chronic Migraine and Clu
2026
·
Βικελής, Μιχαήλ
, Ρίκος, Δημήτριος
, et al.
·
ΑΡΧΕΙΑ ΚΛΙΝΙΚΗΣ ΝΕΥΡΟΛΟΓΙΑΣ
PDF
Show more works
View as search
Works count:
5
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type